Article
ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia
21 Sept 2017
Abstract excerpt
Peroxisome proliferator-activated receptor γ (PPARγ) has been shown to be a therapeutic target for preeclampsia (PE). Angiopoietin-like protein 4 (ANGPTL4) is a multifunctional secretory protein involved in regulating lipid metabolism and angiogenesis in various tissues. However, the expression of PPARγ and ANGPTL4 and their interaction in PE remain elusive. Here we showed that PPARγ agonist rosiglitazone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
